Nextgen Biomed Ltd (TLV: NXGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
70.60
+8.00 (12.78%)
Nov 19, 2024, 5:02 PM IDT

Nextgen Biomed Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
792760808
Upgrade
Market Cap Growth
-61.27%-66.19%-55.05%-24.05%936.11%-9.56%
Upgrade
Enterprise Value
772052785
Upgrade
Last Close Price
0.711.273.768.3714.401.59
Upgrade
PB Ratio
-3.99-9.392.222.9311.596.56
Upgrade
P/TBV Ratio
--2.514.5011.426.05
Upgrade
Debt / Equity Ratio
-0.12-----
Upgrade
Quick Ratio
0.150.114.1613.944.032.50
Upgrade
Current Ratio
0.160.194.1714.124.062.54
Upgrade
Return on Equity (ROE)
-341.38%-251.97%-52.21%-18.57%-32.29%-68.31%
Upgrade
Return on Assets (ROA)
-44.10%-43.30%-11.62%-11.10%-16.19%-30.71%
Upgrade
Return on Capital (ROIC)
-72.09%-58.20%-13.62%-12.90%-20.65%-43.57%
Upgrade
Earnings Yield
-167.90%-154.43%-31.54%-4.22%-1.63%-15.80%
Upgrade
FCF Yield
-37.03%-48.29%-10.13%-4.40%-1.95%-14.92%
Upgrade
Buyback Yield / Dilution
-3.65%-0.53%-8.67%-22.66%-12.16%-
Upgrade
Total Shareholder Return
-3.65%-0.53%-8.67%-22.66%-12.16%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.